Concepedia

Publication | Open Access

An open-label study of pemigatinib in cholangiocarcinoma: final results from FIGHT-202

DOIFull Paper Access

54

Citations

27

References

2024

Year

Arndt Vogel, Vaibhav Sahai, Antoine Hollebecque, Gina M. Vaccaro, Davide Melisi, Raed MAl Rajabi, Andrew Scott Paulson, Mitesh J. Borad, David Gallinson, Adrian Murphy,
ESMO Open

Abstract

Pemigatinib demonstrated durable response and prolonged OS with manageable AEs in patients with previously treated, advanced/metastatic CCA with FGFR2 alterations in the extended follow-up period of FIGHT-202.

References

YearCitations

Page 1